/IMCC.CN
IMCC.CN Stock - IM Cannabis Corp.
Healthcare|Drug Manufacturers - Specialty & GenericCNQ
$5.10-40.00%
$3.40 (-40.00%) • Jun 2
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.83
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IMCC.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.05 – $5.15
TARGET (TP)$5.86
STOP LOSS$4.69
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.17
52W High$9.70
52W Low$1.75
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $54.03M | $48.80M | $54.34M | $34.05M | $15.89M |
| Gross Profit | $8.45M | $9.85M | $9.16M | $6.33M | $10.47M |
| Gross Margin | 15.6% | 20.2% | 16.9% | 18.6% | 65.9% |
| Operating Income | $-10,234,000 | $-12,175,000 | $-30,791,000 | $-23,035,000 | $-8,245,000 |
| Net Income | $-10,585,000 | $-9,498,000 | $-188,890,000 | $-17,763,000 | $-28,698,000 |
| Net Margin | -19.6% | -19.5% | -347.6% | -52.2% | -180.6% |
| EPS | $-4.51 | $-4.45 | $-157.80 | $-2.63 | $-11.40 |
Company Overview
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IMCC.CNBeat Rate
33%
Last 12 quarters
Avg Surprise
-508.6%
EPS vs Estimate
Beats / Misses
4/8
Last 12 quarters
Latest EPS
$0.06
Q2 2025
EPS Surprise History
Q3 23
-271.4%
$-0.26vs$-0.07
Q4 23
+23.8%
$-0.16vs$-0.21
Q4 23
No data
Q2 24
-110.0%
$-0.42vs$-0.20
Q3 24
+80.3%
$-0.23vs$-1.17
Q4 24
+70.9%
$-0.41vs$-1.41
Q4 24
No data
Q2 25
+115.5%
$0.06vs$-0.37
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 12, 2025 | — | — | — | — |
Q2 2025 | May 15, 2025 | $-0.37 | $0.06 | +115.5% | ✓ BEAT |
Q4 2024 | Dec 5, 2024 | — | $-0.37 | — | — |
Q4 2024 | Nov 14, 2024 | $-1.41 | $-0.41 | +70.9% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-1.17 | $-0.23 | +80.3% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.20 | $-0.42 | -110.0% | ✗ MISS |
Q4 2023 | Dec 30, 2023 | — | $-1.52 | — | — |
Q4 2023 | Nov 13, 2023 | $-0.21 | $-0.16 | +23.8% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.07 | $-0.26 | -271.4% | ✗ MISS |
Q1 2023 | Mar 29, 2023 | $-0.32 | $-1.32 | -312.5% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | — | $-4.36 | — | — |
Q4 2022 | Nov 14, 2022 | $-0.60 | $-18.10 | -2916.7% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $0.50 | $-3.00 | -700.0% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.15 | $-1.40 | -833.3% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-1.91 | — | — |
Q4 2021 | Nov 15, 2021 | $-0.20 | $-0.60 | -200.0% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.20 | $-2.30 | -1050.0% | ✗ MISS |
Q2 2021 | May 17, 2021 | — | $-0.60 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IMCC.CN
What is IMCC.CN's current stock price?
IM Cannabis Corp. (IMCC.CN) is currently trading at $5.10 per share. The stock has moved -40.00% today.
What is the analyst price target for IMCC.CN?
No analyst price targets are currently available for this stock.
What sector is IM Cannabis Corp. in?
IM Cannabis Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the CNQ exchange.
What is IMCC.CN's market cap?
IM Cannabis Corp. has a market capitalization of $0.02 billion, making it a small-cap company.
Does IMCC.CN pay dividends?
No, IM Cannabis Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAYR-A.CN
Ayr Wellness Inc.
$0.15
Mkt Cap: $0.0B
CHAL.CN
Chalice Brands Ltd.
$0.23
Mkt Cap: $0.0B
EXM.CN
EXMceuticals Inc.
$0.20
Mkt Cap: $0.0B
MRV.TO
Nuvo Pharmaceuticals Inc.
$1.35
Mkt Cap: $0.0B
NUMI.TO
Numinus Wellness Inc.
$0.05
Mkt Cap: $0.0B
ORI.CN
Orion Nutraceuticals Inc.
$0.40
Mkt Cap: $0.0B
REUN.TO
Reunion Neuroscience Inc.
$1.42
Mkt Cap: $0.0B
RIV.CN
RIV Capital Inc.
$0.10
Mkt Cap: $0.0B
SGMD.V
Salona Global Medical Device Corporation
$0.22
Mkt Cap: $0.0B
VIN.CN
Vinergy Capital Inc.
$0.20
Mkt Cap: $0.0B
Explore stocks similar to IMCC.CN for comparison